DAM
ACHV icon

DLD Asset Management’s Achieve Life Sciences ACHV Stock Holding History

DLD Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,528
Closed -$345K – 228
2022
Q1 		$345K Buy
+45,528
New +$339K 0.02% 186

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DLD Asset Management's ACHV Position: Q2 2022 in Review

DLD Asset Management sold out of Achieve Life Sciences (ACHV) in Q2 2022, closing a stake of 45,528 shares — an estimated $345K sold.

DLD Asset Management first reported a position in ACHV in Q1 2022 and held it in 1 quarter. The position peaked at $345K in Q1 2022. 31 funds tracked by Wall St. Rank hold ACHV as of Q2 2022.

  • DLD Asset Management reported no remaining Achieve Life Sciences position as of Q2 2022 after selling out during the quarter.
  • DLD Asset Management sold 45,528 Achieve Life Sciences shares in Q2 2022, an estimated $345K.
  • DLD Asset Management first reported a position in Achieve Life Sciences in Q1 2022 and held it in 1 quarter.
  • DLD Asset Management's Achieve Life Sciences position peaked at $345K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2022.

Based on DLD Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.